Pulmonary Hypertension and Atrial Septal Defect: Management Dilemma

    loading  Checking for direct PDF access through Ovid

Abstract

The decision making in patients with an atrial septal defect (ASD) in setting of pulmonary hypertension is complex. In the era of pulmonary arterial vasodilator therapy, every patient should undergo evaluation by pulmonary hypertension experts especially if defect closure is being considered. Defect closure in the inappropriate group can lead to poor outcomes.

Related Topics

    loading  Loading Related Articles